Literature DB >> 3192859

Mortality from asthma, 1979-1984.

R M Sly1.   

Abstract

Review of data from the National Center for Health Statistics to characterize deaths from asthma disclosed increases in rates of death from 1.2 per 100,000 in 1979 to 1.5 in 1983 and 1984. For black subjects, rates of death from asthma increased from 1.8 in 1979 to 2.5 in 1984; for white subjects, from 1.1 in 1979 to 1.4 in 1984. Age-adjusted rates of death from asthma increased from 1.9 in 1979 to 2.8 in 1983 and 2.6 in 1984 for black subjects, and from 0.8 to 1979 to 1.0 in 1984 for white subjects. Rates for other minority groups have been lower than rates for white subjects. A modest increase in prevalence of asthma among black subjects is insufficient to account for their much higher rate of death from asthma. Increases in rates of death have occurred in both metropolitan and nonmetropolitan areas in all regions of the country and in all but a few states. At least half the deaths from asthma have occurred at hospitals: this proportion did not change from 1979 to 1984. Increases in deaths from asthma have occurred in several other countries as well. Other reviews of deaths from asthma have implicated undertreatment and delays in treatment with bronchodilators and adrenal corticosteroids as factors contributing to death. High rates of death among black subjects suggest underutilization or lack of accessibility of health care. The large proportion of deaths that have occurred at hospitals suggests delays or other inadequacies of treatment at hospitals.

Entities:  

Mesh:

Year:  1988        PMID: 3192859     DOI: 10.1016/0091-6749(88)90069-3

Source DB:  PubMed          Journal:  J Allergy Clin Immunol        ISSN: 0091-6749            Impact factor:   10.793


  13 in total

1.  Targeting asthma care in general practice using a morbidity index.

Authors:  K P Jones; I H Charlton; M Middleton; W J Preece; A P Hill
Journal:  BMJ       Date:  1992-05-23

2.  Interaction of asthmatics and their spouses: A preliminary study of individual differences.

Authors:  K B Schmaling; F Wamboldt; L Telford; K B Newman; H Hops; J M Eddy
Journal:  J Clin Psychol Med Settings       Date:  1996-09

3.  Mortality in patients hospitalized for asthma exacerbations in the United States.

Authors:  Vidya Krishnan; Gregory B Diette; Cynthia S Rand; Andrew L Bilderback; Barry Merriman; Nadia N Hansel; Jerry A Krishnan
Journal:  Am J Respir Crit Care Med       Date:  2006-06-15       Impact factor: 21.405

4.  Chronic respiratory illness as a predictor of survival in idiopathic dilated cardiomyopathy: the Washington, DC, Dilated Cardiomyopathy Study.

Authors:  S A Martin; S S Coughlin; C Metayer; A A René; I W Hammond
Journal:  J Natl Med Assoc       Date:  1996-11       Impact factor: 1.798

5.  Trends in asthma mortality among African Americans and whites in Chicago, 1968 through 1991.

Authors:  P V Targonski; V W Persky; P Orris; W Addington
Journal:  Am J Public Health       Date:  1994-11       Impact factor: 9.308

6.  Demographic characteristics of patients with severe life threatening asthma: comparison with asthma deaths.

Authors:  G N Richards; J Kolbe; J Fenwick; H H Rea
Journal:  Thorax       Date:  1993-11       Impact factor: 9.139

7.  Correlates of asthma morbidity in primary care.

Authors:  K P Jones; D J Bain; M Middleton; M A Mullee
Journal:  BMJ       Date:  1992-02-08

8.  Why are hospital admission and mortality rates for childhood asthma higher in New Zealand than in the United Kingdom?

Authors:  E A Mitchell; H R Anderson; P Freeling; P T White
Journal:  Thorax       Date:  1990-03       Impact factor: 9.139

9.  Characteristics of attenders and non-attenders at an asthma education programme.

Authors:  R Yoon; D K McKenzie; D A Miles; A Bauman
Journal:  Thorax       Date:  1991-12       Impact factor: 9.139

Review 10.  The beta 2-agonist controversy. Observations, explanations and relationship to asthma epidemiology.

Authors:  M R Sears; D R Taylor
Journal:  Drug Saf       Date:  1994-10       Impact factor: 5.606

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.